Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 18.44% Profit

May 03, 2023
QuantWave's forecast for ELI LILLY AND COMPANY stock proved to be highly accurate, as the predicted long direction signal on November 25, 2022, successfully reached its target on May 3, 2023. The stock price at the time of the signal was $357.99, and it reached $423.98, delivering a significant profit of 18.44%.

This achievement showcases the precision and effectiveness of QuantWave's analytics in providing valuable insights for investors. The market analysis indicated favorable conditions for ELI LILLY AND COMPANY, possibly driven by strong financial performance, industry trends, or other factors contributing to the stock's movement.

QuantWave is a leading automated forecasting platform that offers predictions for a wide range of stocks, presenting opportunities for potential profits. For investors seeking to deepen their understanding of the investment strategy behind QuantWave, QuantSchool provides comprehensive educational resources outlining key principles for generating consistent income using the forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

BACDecember 14, 2023QuantWave Successfully Achieves 10.99% Profit Target Forecast for BANK OF AMERICA CORPORATION Stock  ~1 min.

On December 5, 2023, QuantWave, the leading automated forecasting platform, issued a signal for BANK OF AMERICA CORPORATION stock, predicting a long position with a price of 29.63 $....

ROKApril 4, 2025QuantWave Successfully Achieves Price Target Forecast for ROCKWELL AUTOMATION, INC. with 12.53% Profit  ~1 min.

On September 10, 2024, QuantWave, an automated forecasting platform, issued a signal for ROCKWELL AUTOMATION, INC. with a forecasted direction of short and a price of 258.53 $....

CMEMarch 10, 2025QuantWave Achieves 15.8% Profit Target Forecast for CME GROUP INC.  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for CME GROUP INC., generating a profit of 15.8%....

METAOctober 27, 2022QuantWave Successfully Achieves 24.83% Profit Target Forecast for Meta Platforms, Inc.  ~2 min.

On October 13, 2022, QuantWave, the automated forecasting platform, issued a short signal for META PLATFORMS, INC. (formerly known as Facebook, Inc.) with a price target of $97.41....

UPSFebruary 3, 2025QuantWave Successfully Achieves 11.74% Profit Target Forecast for United Parcel Service, Inc. Stock  ~2 min.

On December 31, 2024, QuantWave, the automated forecasting platform, signaled a short direction forecast for United Parcel Service, Inc. stock (UPS) when it was trading at $122.31....